INO Therapeutics LLC

INO Therapeutics LLC is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of respiratory and cardiovascular diseases. Their main drug, INOmax (nitric oxide), is used to treat infants with hypoxic respiratory failure and has been proven effective in improving oxygenation and reducing the need for extracorporeal membrane oxygenation (ECMO). The company was founded in 1995 and is known for its expertise in inhaled nitric oxide therapy.